211 related articles for article (PubMed ID: 27966069)
1. ImmunoPET Imaging of Murine CD4
Freise AC; Zettlitz KA; Salazar FB; Lu X; Tavaré R; Wu AM
Mol Imaging Biol; 2017 Aug; 19(4):599-609. PubMed ID: 27966069
[TBL] [Abstract][Full Text] [Related]
2. Immuno-PET in Inflammatory Bowel Disease: Imaging CD4-Positive T Cells in a Murine Model of Colitis.
Freise AC; Zettlitz KA; Salazar FB; Tavaré R; Tsai WK; Chatziioannou AF; Rozengurt N; Braun J; Wu AM
J Nucl Med; 2018 Jun; 59(6):980-985. PubMed ID: 29326360
[TBL] [Abstract][Full Text] [Related]
3. Immuno-PET of Murine T Cell Reconstitution Postadoptive Stem Cell Transplantation Using Anti-CD4 and Anti-CD8 Cys-Diabodies.
Tavaré R; McCracken MN; Zettlitz KA; Salazar FB; Olafsen T; Witte ON; Wu AM
J Nucl Med; 2015 Aug; 56(8):1258-64. PubMed ID: 25952734
[TBL] [Abstract][Full Text] [Related]
4. ImmunoPET of Malignant and Normal B Cells with
Zettlitz KA; Tavaré R; Knowles SM; Steward KK; Timmerman JM; Wu AM
Clin Cancer Res; 2017 Dec; 23(23):7242-7252. PubMed ID: 28928164
[No Abstract] [Full Text] [Related]
5. Mechanisms of anti-CD4-mediated depletion and immunotherapy. A study using a set of chimeric anti-CD4 antibodies.
Alters SE; Sakai K; Steinman L; Oi VT
J Immunol; 1990 Jun; 144(12):4587-92. PubMed ID: 1972161
[TBL] [Abstract][Full Text] [Related]
6.
Zettlitz KA; Tavaré R; Tsai WK; Yamada RE; Ha NS; Collins J; van Dam RM; Timmerman JM; Wu AM
Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):489-500. PubMed ID: 30456475
[TBL] [Abstract][Full Text] [Related]
7. In vivo tracking of Th1 cells by PET reveals quantitative and temporal distribution and specific homing in lymphatic tissue.
Griessinger CM; Kehlbach R; Bukala D; Wiehr S; Bantleon R; Cay F; Schmid A; Braumüller H; Fehrenbacher B; Schaller M; Eichner M; Sutcliffe JL; Ehrlichmann W; Eibl O; Reischl G; Cherry SR; Röcken M; Pichler BJ; Kneilling M
J Nucl Med; 2014 Feb; 55(2):301-7. PubMed ID: 24434289
[TBL] [Abstract][Full Text] [Related]
8. ImmunoPET Imaging of α
White JB; Hu LY; Boucher DL; Sutcliffe JL
Mol Imaging Biol; 2018 Feb; 20(1):103-113. PubMed ID: 28653240
[TBL] [Abstract][Full Text] [Related]
9. CD8
Seo JW; Tavaré R; Mahakian LM; Silvestrini MT; Tam S; Ingham ES; Salazar FB; Borowsky AD; Wu AM; Ferrara KW
Clin Cancer Res; 2018 Oct; 24(20):4976-4987. PubMed ID: 29967252
[No Abstract] [Full Text] [Related]
10. Effect of GK1.5 monoclonal antibody dosage on survival of pig proislet xenografts in CD4+ T cell-depleted mice.
Simeonovic CJ; Ceredig R; Wilson JD
Transplantation; 1990 May; 49(5):849-56. PubMed ID: 1970911
[TBL] [Abstract][Full Text] [Related]
11. Prevention and reversal of experimental autoimmune thyroiditis (EAT) in mice by administration of anti-L3T4 monoclonal antibody at different stages of disease development.
Stull SJ; Kyriakos M; Sharp GC; Braley-Mullen H
Cell Immunol; 1988 Nov; 117(1):188-98. PubMed ID: 2902931
[TBL] [Abstract][Full Text] [Related]
12. Engineered antibody fragments for immuno-PET imaging of endogenous CD8+ T cells in vivo.
Tavaré R; McCracken MN; Zettlitz KA; Knowles SM; Salazar FB; Olafsen T; Witte ON; Wu AM
Proc Natl Acad Sci U S A; 2014 Jan; 111(3):1108-13. PubMed ID: 24390540
[TBL] [Abstract][Full Text] [Related]
13. Differences in the degree of depletion, rate of recovery, and the preferential elimination of naive CD4+ T cells by anti-CD4 monoclonal antibody (GK1.5) in young and aged mice.
Rice JC; Bucy RP
J Immunol; 1995 Jun; 154(12):6644-54. PubMed ID: 7539027
[TBL] [Abstract][Full Text] [Related]
14. An engineered anti-CA19-9 cys-diabody for positron emission tomography imaging of pancreatic cancer and targeting of polymerized liposomal nanoparticles.
Girgis MD; Federman N; Rochefort MM; McCabe KE; Wu AM; Nagy JO; Denny C; Tomlinson JS
J Surg Res; 2013 Nov; 185(1):45-55. PubMed ID: 23827791
[TBL] [Abstract][Full Text] [Related]
15. Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen-induced arthritis: influence on T helper cell activation.
Pohlers D; Nissler K; Frey O; Simon J; Petrow PK; Kinne RW; Bräuer R
Clin Exp Immunol; 2004 Mar; 135(3):409-15. PubMed ID: 15008972
[TBL] [Abstract][Full Text] [Related]
16. ImmunoPET Imaging of Insulin-Like Growth Factor 1 Receptor in a Subcutaneous Mouse Model of Pancreatic Cancer.
England CG; Kamkaew A; Im HJ; Valdovinos HF; Sun H; Hernandez R; Cho SY; Dunphy EJ; Lee DS; Barnhart TE; Cai W
Mol Pharm; 2016 Jun; 13(6):1958-66. PubMed ID: 27054683
[TBL] [Abstract][Full Text] [Related]
17. ImmunoPET imaging of tissue factor expression in pancreatic cancer with
Hernandez R; England CG; Yang Y; Valdovinos HF; Liu B; Wong HC; Barnhart TE; Cai W
J Control Release; 2017 Oct; 264():160-168. PubMed ID: 28843831
[TBL] [Abstract][Full Text] [Related]
18. Immuno-PET imaging of tumor-infiltrating lymphocytes using zirconium-89 radiolabeled anti-CD3 antibody in immune-competent mice bearing syngeneic tumors.
Beckford Vera DR; Smith CC; Bixby LM; Glatt DM; Dunn SS; Saito R; Kim WY; Serody JS; Vincent BG; Parrott MC
PLoS One; 2018; 13(3):e0193832. PubMed ID: 29513764
[TBL] [Abstract][Full Text] [Related]
19. ImmunoPET imaging of CD38 in murine lymphoma models using
Kang L; Jiang D; England CG; Barnhart TE; Yu B; Rosenkrans ZT; Wang R; Engle JW; Xu X; Huang P; Cai W
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1372-1381. PubMed ID: 29450576
[TBL] [Abstract][Full Text] [Related]
20. Comparison of rat and rat-mouse chimeric anti-murine CD4 antibodies in vitro. Chimeric antibodies lyse low-density CD4+ cells.
Alters SE; Steinman L; Oi VT
J Immunol; 1989 Mar; 142(6):2018-23. PubMed ID: 2466082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
